Associazione Nazionale Medici Cardiologi Ospedalieri

www.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
Sex Differences in Clinical Characteristics and Outcomes of Patients Undergoing Catheter-Directed Treatments for High Risk and Intermediate-High Risk Acute Pulmonary Embolism. Do we need Sex-specific Considerations in the Management of Acute PE?
Anno:
2024
Background: Acute pulmonary embolism (PE) is a common disease associated with a high mortality rate. Catheter-Directed Treatments (CDTs) could address some unsolved issues in high and intermediate-high risk PE patients evolving towards hemodynamic deterioration when systemic thrombolysis (ST) is contraindicated or fails. Few data in literature suggest that female…
Leggi di più
A CASE OF RIGHT HEART FAILURE: WHEN IT IS NOT PULMONARY EMBOLISM
Anno:
2024
A 66-year-old patient, showing exertional dyspnea and atypical chest pain, came to our attention with instrumental findings at echocardiogram of right ventricular failure and was hospitalized due to worsening signs and symptoms of right heart failure. Signs of right ventricular strain and the McGinn-White sign (S1Q3T3 pattern) were seen…
Leggi di più
Half dose thrombolysis in intermediate – high risk pulmonary embolism with tricuspid valve mobile mass: a bail out strategy
Anno:
2024
A 82-year-old previously healthy male was referred to the emergency department complaining sudden onset dyspnea and witnessed syncope complicated by head trauma. Recurrent dizziness occurred previously. No history or drug consumption noted. On admission: heart rate 90 beats/min, blood pressure 110/60 mmHg, respiratory rate 25 breaths/min, oxygen saturation 87%…
Leggi di più
ACUTE PULMONARY EMBOLISM: NEW HORIZONS IN CAT LAB
Anno:
2024
Pulmonary embolism (PE) has an incidence of 30-100 cases per 100,000 inhabitants per year and is one of the main causes of cardiovascular mortality.The 2019 ESC guidelines suggest treating patients at intermediate-high risk with heparin, discouraging thrombolysis and leaving embolectomy to the clinician ‘s judgment in case of impending…
Leggi di più
HALF-DOSE THROMBOLYSIS IN HIGH-RISK PULMONARY EMBOLISM
Anno:
2024
An 87-year-old woman was admitted to our Emergency Department because of two syncopal episodes with head trauma. BP was 100/60 mmHg and HR was 150 bpm in atrial fibrillation. Lab tests showed elevation of NT-proBNP(9000 pg/mL)and serum lactate(4 mmol/L). Echocardiography revealed a large floating thrombus in the right atrium,as…
Leggi di più
An acute event as sign of a chronic process
Anno:
2024
A 66-years-old woman was admitted to the Emergency Department with dyspnea at rest. 11 days earlier she had undergone surgery because of femoral fracture. The Computed Tomographic Pulmonary Angiogram (CT Angiogram) confirmed the diagnosis of Pulmonary Embolism (PE). Patient was transferred to Cardiac Intensive Care Unit were Echocardiogram showed…
Leggi di più
Effectiveness and safety of half-dose thrombolysis in intermediate-high risk pulmonary embolism: a retrospective, single center experience
Anno:
2024
BACKGROUND: Current guidelines recommend full-dose systemic thrombolysis for acute pulmonary embolism (PE) in high-risk or hemodynamically unstable intermediate-high risk (IHR- PE) patients. Recent trials suggest that a low, half dose (50 mg) of tissue plasminogen activator (HDrtPA) could be a safe, effective alternative with low bleeding risk. We aimed…
Leggi di più
A CASE OF PARADOXICAL PULMONARY EMBOLISM AS CAUSE OF RENAL INFARCTION: IT’S TIME FOR USAT
Anno:
2024
Case report: a 67 years old Angolan woman was referred to our hospital for worsen dyspnea, palpitation and left flank pain while walking. She had no relevant medical history and her only cardiovascular (CV) risk factor was hypertension. For high suspicion of pulmonary embolism (PE), an abdominal-thoracic CT was…
Leggi di più

A.N.M.C.O. – Via La Marmora 36, 50121 Firenze (Italy) – Partita I.V.A. 05469530488 – Codice Fiscale 01301130488 – Privacy
www.anmco.it | segreteria@anmco.it

Cookie Policy Privacy Policy

Seguici su

Facebook Twitter Youtube Linkedin Instagram Telegram